Memorial Sloan Kettering Radiation Oncology – Phase II trial shows the rate of implant failure in reconstructed patients with breast cancer

Memorial Sloan Kettering Radiation Oncology shared on X:

“New in International Journal of Radiation Oncology, Biology, Physics: Phase II trial shows the rate of implant failure in reconstructed patients with breast cancer treated with IMRT was similar to, but not improved over, conventional, 3D-conformal radiation. Breast cancer serial MRIs may detect early capsular contracture.”

Proceed to the article.
Source: Memorial Sloan Kettering Radiation Oncology/X